Literature DB >> 68783

Radioimmunoassay of bleomycin in plasma and urine.

J D Teale, J M Clough, V Marks.   

Abstract

Antibodies to bleomycin were raised by immunization of sheep and rabbits with bleomycin-albumin conjugates. The combination of a high-titre, high-avidity sheep antiserum and iodinated bleomycin produced a radioimmunoassay sensitive to 8 ng of bleomycin per ml of plasma or urine. Untreated specimens (100 microliter) of plasma or urine could be added directly to the assay tubes. The antiseerum was specific for bleomycin and showed no cross-reaction with other anticancer agents used in combination chemotherapy. Over a concentration range of 20-100 ng/ml, recovery of bleomycin from plasma was 110% and from urine, 93%. Repeated assay of plasma samples showed a decrease in bleomycin levels unless the samples were kept at 4 degrees C or below. Assay of bleomycin levels in plasma and urine from patients under treatment with bleomycin showed similarities with results reported using a microbiological assay. The radioimmunoassay offers a more reliable, rapid and sensitive method for the measurement of bleomycin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68783      PMCID: PMC2025532          DOI: 10.1038/bjc.1977.124

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Studies on bleomycin: chemistry and the biological action.

Authors:  H Umezawa
Journal:  Biomedicine       Date:  1973-11

2.  Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.

Authors:  T Onuma; J F Holland; H Masuda; J A Waligunda; G A Goldberg
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

3.  The development of a radioimmunoassay for cannabinoids in blood and urine.

Authors:  J D Teale; E J Forman; L J King; E M Piall; V Marks
Journal:  J Pharm Pharmacol       Date:  1975-07       Impact factor: 3.765

4.  Synthesis and the lethality of bleomycin in bacteria.

Authors:  S S Cohen; J I
Journal:  Cancer Res       Date:  1976-08       Impact factor: 12.701

5.  Radioimmunoassay of vinblastine and vincristine.

Authors:  J D Teale; J M Clough; V Marks
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

  5 in total
  7 in total

Review 1.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline.

Authors:  M L Slevin; V J Harvey; G W Aherne; N K Burton; A Johnston; P F Wrigley
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Target-induced activation of DNAzyme for highly sensitive colorimetric detection of bleomycin via DNA scission.

Authors:  Xiaofei Liao; Mengyan Li; Li Zou
Journal:  RSC Adv       Date:  2022-06-22       Impact factor: 4.036

4.  Molecular beacon-templated silver nanoclusters as a fluorescent probe for determination of bleomycin via DNA scission.

Authors:  Xiaolu Yan; Jing Sun; Xian-En Zhao; Renjun Wang; Xiao Wang; Ya-Nan Zuo; Wei Liu; Rongmei Kong; Shuyun Zhu
Journal:  Mikrochim Acta       Date:  2018-08-06       Impact factor: 5.833

5.  New Delhi metallo-β-lactamase 4-producing Escherichia coli in Cameroon.

Authors:  Laurent Dortet; Laurent Poirel; Nadia Anguel; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

6.  Enhancement of human chorionic gonadotrophin production by antimetabolites.

Authors:  P Browne; K D Bagshawe
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

7.  A radioimmunoassay for cytosine arabinoside.

Authors:  E M Piall; G W Aherne; V M Marks
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.